RCT: Added Value of Coordinator for the Management of Hip Fracture Patients
NCT ID: NCT01785381
Last Updated: 2013-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
128 participants
INTERVENTIONAL
2012-12-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: To evaluate whether a coordinator increases the optimal management of osteoporotic fracture patients and hip fracture patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture
NCT06152198
RCT Determining Best Treatment for Geriatric Acetabular Fractures
NCT03419182
Waiting Time to Operation for Hip-fracture Patients
NCT01488812
External Validation of Ten Prediction Models for 30-day Mortality Following Hip Fracture
NCT06961253
Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program
NCT02297581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First observational phase of treatment followed by randomized controlled trials of 2 years.
Intervention (RCT): Added value of a coordinator. Measured outcomes : A. New fractures. B. A score of optimal management of osteoporosis.
Definition of the score and management: 1. Realization of a bone density measurement. 2. Identification of secondary osteoporosis. 3. Identification of risk factors and calculation of the probability of a future fracture using FRAX score. 4. Attempt to correct risk factors of osteoporosis when possible. 5. Prevention of falls. 6. Prescription of calcium and vitamin D. 7. Prescription of a medical osteoporosis treatment. 8. Report to the general practitioner.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual care
usual care
No interventions assigned to this group
Added value of coordinator
Added value of coordinator
Added value of coordinator
Added value of coordinator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Added value of coordinator
Added value of coordinator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Saint Pierre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nyaruhirira Innocent
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRIS Hospitals
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRIS recherche 2012820690007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.